Coronado Research Welcomes Nick Littlebury as New EVP
Coronado Research has appointed Nick Littlebury to the role of Executive Vice President for Regulatory Affairs, bringing in a wealth of experience and strategic insight. With a robust background in the pharmaceutical industry, Nick has excelled in navigating complex regulatory environments throughout his career.
A Proven Leader in Regulatory Affairs
Nick Littlebury is renowned for his senior regulatory leadership across various facets of the pharmaceutical product lifecycle. His experience spans important roles in the UK and Europe, where he has effectively spearheaded regulatory teams and developed innovative solutions tailored for global clients. This breadth of knowledge positions him perfectly to guide Coronado Research in the evolving regulatory landscape.
Vision and Commitment to Innovation
Andrew MacGarvey, the CEO of Coronado Research, expressed confidence in Nick's capabilities, stating, “Nick brings a wealth of regulatory knowledge and passion for regulatory affairs transformation that aligns perfectly with the Coronado mission. His emphasis on cross-functional collaboration will be vital for delivering integrated solutions to our clients.” Andrew added that Nick's vast experience equips him to create optimized solutions by integrating diverse perspectives from the sponsor, regulatory authorities, and service provision fields.
Transforming Regulatory Affairs with Technology
Commenting on his new position, Nick highlighted the dynamic nature of regulatory affairs, stating, “Companies continuously evaluate how to best navigate the regulatory landscape. Coronado's innovative approach to blend science with technology positions us uniquely in the market.”
Embracing AI and Automation
As advancements in artificial intelligence (AI) and automation redefine operational efficiencies, Nick emphasized the importance of these technologies in reducing regulatory burdens. He believes that by leveraging these advancements, Coronado will help companies prioritize what truly matters: the well-being of patients.
About Coronado Research
Coronado Research operates as a consultancy-led professional services organization, aiming to provide critical support to entities in the pharmaceutical, biotechnology, and medical device sectors. Their objective is to enhance the clinical development process by utilizing vast amounts of data through AI, machine learning (ML), and cutting-edge technologies.
Comprehensive Service Offerings
The services offered by Coronado include Regulatory Strategy, Advanced Analytics, Market Access, Health Economics, and Technology. Aiming for an integrated approach, the teams at Coronado are committed to connecting the dots among various disciplines, ensuring that treatments are developed with consumer needs in mind while effectively addressing market demands.
Contact Information
For further inquiries, interested parties can reach out to Coronado Research directly, ensuring all communications are handled efficiently.
Frequently Asked Questions
Who is Nick Littlebury?
Nick Littlebury is the newly appointed Executive Vice President of Regulatory Affairs at Coronado Research with extensive experience in the pharmaceutical industry.
What is Coronado Research's focus?
Coronado Research focuses on optimizing the clinical development process for pharmaceutical, biotechnology, and medical device companies using technology and data.
How does Coronado Research leverage technology?
Coronado utilizes AI and ML alongside other leading technologies to improve regulatory strategies and the overall drug development process.
Why is regulatory affairs important?
Regulatory affairs are vital as they ensure compliance with laws and regulations affecting product efficacy, safety, and quality in the healthcare sector.
What services does Coronado Research provide?
The company offers services such as Regulatory Strategy, Market Access, Advanced Analytics, and Health Economics to streamline the development process.
